AUTISM DISORDER TREATMENT MARKET ANALYSIS

Regional Analysis

Regional Insights

On the basis of region, the global autism disorder treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant position in the global autism disorder treatment market, owing to increasing product development by key players in the region, rising number of autistic patients as well as increasing government initiatives for treatment of the disease. According to Centers of Disease Control & Prevention’s (CDC) Autism and Developmental Disabilities Monitoring (ADDM) Network 2014, around 1 in 59 children were identified with autism spectrum disorder (ASD), and was reported to be four times more common among boys than girls. Moreover, according to Talk About Curing Autism (TACA), a U.S.-based non-profit organization dedicated to supporting patients with autism, the disease is the fastest growing developmental disability in the U.S. that cost over US$ 238 billion per year to the nation in 2016.

Furthermore, Asia Pacific is expected to witness significant traction in the global autism disorder treatment market in the near future. This is owing to various governmental efforts and non-profit organizations working collaboratively to aid in treatment of the disease by spreading awareness as well supporting patients with medicines and required therapies. For instance, Action for Autism by the National Center for Autism India pioneered autism movement in India and South-Asia for empowering lives of patients suffering with autism through conducting “Global Giving Program” named Ananda and various other initiatives. This non-profit organization is supported by Department of Social Welfare, Government of India, and it is expected to provide medical and economic support to over 3,000 families in India in 2017.